Back to Search Start Over

Delayed drug hypersensitivity reaction to secukinumab in a patient with hidradenitis suppurativa.

Authors :
Konda S
Shetty N
Friedman B
Veenstra J
Source :
BMJ case reports [BMJ Case Rep] 2022 May 17; Vol. 15 (5). Date of Electronic Publication: 2022 May 17.
Publication Year :
2022

Abstract

A woman in her 30s presented to the dermatology clinic with widespread, pruritic, red papules and plaques involving the ears, trunk and extremities. The rash developed a few days after receiving her second injection of secukinumab, which was initiated for recalcitrant Hurley stage III hidradenitis suppurativa. Investigations revealed a psoriasiform drug hypersensitivity reaction secondary to secukinumab. In this report, we describe the clinical course, histopathological correlation and treatment of this rarely documented reaction.<br />Competing Interests: Competing interests: None declared.<br /> (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1757-790X
Volume :
15
Issue :
5
Database :
MEDLINE
Journal :
BMJ case reports
Publication Type :
Academic Journal
Accession number :
35580946
Full Text :
https://doi.org/10.1136/bcr-2022-249684